Grilley-Olson, J. E., Allred, J. B., Schuetze, S., Davis, E. J., Poklepovic, A. S., Wagner, M. J., … Schwartz, G. K. (2024). Alliance A091902: A multicenter randomized phase II trial of paclitaxel (P) with or without nivolumab (N) in patients (pts) with advanced angiosarcoma (AS). In JOURNAL OF CLINICAL ONCOLOGY (Vol. 42).

Grilley-Olson, Juneko E., Jacob B. Allred, Scott Schuetze, Elizabeth J. Davis, Andrew Stewart Poklepovic, Michael J. Wagner, Richard F. Riedel, et al. “Alliance A091902: A multicenter randomized phase II trial of paclitaxel (P) with or without nivolumab (N) in patients (pts) with advanced angiosarcoma (AS).” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 42, 2024.

Grilley-Olson JE, Allred JB, Schuetze S, Davis EJ, Poklepovic AS, Wagner MJ, et al. Alliance A091902: A multicenter randomized phase II trial of paclitaxel (P) with or without nivolumab (N) in patients (pts) with advanced angiosarcoma (AS). In: JOURNAL OF CLINICAL ONCOLOGY. 2024.

Grilley-Olson, Juneko E., et al. “Alliance A091902: A multicenter randomized phase II trial of paclitaxel (P) with or without nivolumab (N) in patients (pts) with advanced angiosarcoma (AS).” JOURNAL OF CLINICAL ONCOLOGY, vol. 42, no. 16, 2024.

Grilley-Olson JE, Allred JB, Schuetze S, Davis EJ, Poklepovic AS, Wagner MJ, Riedel RF, Hartranft A, Welliver MX, Berg SA, George S, Robinson SI, Googe PB, D’Angelo SP, Schwartz GK. Alliance A091902: A multicenter randomized phase II trial of paclitaxel (P) with or without nivolumab (N) in patients (pts) with advanced angiosarcoma (AS). JOURNAL OF CLINICAL ONCOLOGY. 2024.